141 related articles for article (PubMed ID: 38349968)
1. Mechanisms of biased agonism by Gα
Jayakody T; Inoue A; Kannan S; Nakamura G; Kawakami K; Mendis K; Nguyen TB; Li J; Herr DR; Verma CS; Dawe GS
Sci Signal; 2024 Feb; 17(823):eabl5880. PubMed ID: 38349968
[TBL] [Abstract][Full Text] [Related]
2. Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity.
Jayakody T; Marwari S; Lakshminarayanan R; Tan FC; Johannes CW; Dymock BW; Poulsen A; Herr DR; Dawe GS
Peptides; 2016 Oct; 84():44-57. PubMed ID: 27498038
[TBL] [Abstract][Full Text] [Related]
3. Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.
Kocan M; Ang SY; Summers RJ
Neurochem Res; 2016 Mar; 41(3):610-9. PubMed ID: 26294284
[TBL] [Abstract][Full Text] [Related]
4. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
[TBL] [Abstract][Full Text] [Related]
5. Identification of hydrophobic interactions between relaxin-3 and its receptor RXFP3: implication for a conformational change in the B-chain C-terminus during receptor binding.
Hu MJ; Shao XX; Wang JH; Wei D; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2016 Sep; 48(9):2227-36. PubMed ID: 27193232
[TBL] [Abstract][Full Text] [Related]
6. Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.
Wong LLL; Scott DJ; Hossain MA; Kaas Q; Rosengren KJ; Bathgate RAD
J Biol Chem; 2018 Oct; 293(41):15777-15789. PubMed ID: 30131340
[TBL] [Abstract][Full Text] [Related]
7. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
8. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
9. Binding conformation and determinants of a single-chain peptide antagonist at the relaxin-3 receptor RXFP3.
Haugaard-Kedström LM; Lee HS; Jones MV; Song A; Rathod V; Hossain MA; Bathgate RAD; Rosengren KJ
J Biol Chem; 2018 Oct; 293(41):15765-15776. PubMed ID: 30131342
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.
Kania A; Gugula A; Grabowiecka A; de Ávila C; Blasiak T; Rajfur Z; Lewandowski MH; Hess G; Timofeeva E; Gundlach AL; Blasiak A
J Physiol; 2017 Jun; 595(11):3425-3447. PubMed ID: 28098344
[TBL] [Abstract][Full Text] [Related]
11. The highly conserved negatively charged Glu141 and Asp145 of the G-protein-coupled receptor RXFP3 interact with the highly conserved positively charged arginine residues of relaxin-3.
Zhang WJ; Wang XY; Guo YQ; Luo X; Gao XJ; Shao XX; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2014 May; 46(5):1393-402. PubMed ID: 24615237
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol modulates the binding properties of human relaxin family peptide receptor 3 with its ligands.
Wang JH; Hu MJ; Shao XX; Wei D; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2018 May; 646():24-30. PubMed ID: 29601823
[TBL] [Abstract][Full Text] [Related]
13. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay.
Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565
[TBL] [Abstract][Full Text] [Related]
15. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
Haugaard-Kedström LM; Shabanpoor F; Hossain MA; Clark RJ; Ryan PJ; Craik DJ; Gundlach AL; Wade JD; Bathgate RA; Rosengren KJ
J Am Chem Soc; 2011 Apr; 133(13):4965-74. PubMed ID: 21384867
[TBL] [Abstract][Full Text] [Related]
17. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.
DeChristopher B; Park SH; Vong L; Bamford D; Cho HH; Duvadie R; Fedolak A; Hogan C; Honda T; Pandey P; Rozhitskaya O; Su L; Tomlinson E; Wallace I
Bioorg Med Chem Lett; 2019 Apr; 29(8):991-994. PubMed ID: 30824200
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
[TBL] [Abstract][Full Text] [Related]
20. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
